rediem | $1,200,000 | (Dec 4, 2024)
Fello(US) | $10,400,000 | (Dec 4, 2024)
Refoxy Pharma | $9,561,279 | (Dec 4, 2024)
Predicta Biosciences
United States
- Cambridge, Massachusetts
- 17/07/2024
- Seed
- $5,200,000
Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
- Industry Biotechnology Research
- Website https://www.predictabiosciences.com/
- LinkedIn https://www.linkedin.com/company/predicta-biosciences/
Related People
Kate (Gallagher) CavesFounder
United States -
Greater Boston
Executive Leader with Business Development, Corporate Development, Marketing and deep technical background in Therapeutic Development and Diagnostic tools. Passionate about the intersection of Biology, Healthcare, and AI.
Stackfix | $3,000,000 | (Dec 4, 2024)
Eagle Electronics | $14,000,000 | (Dec 4, 2024)
Droxi | $21,000,000 | (Dec 4, 2024)
Maze Therapeutics | $115,000,000 | (Dec 4, 2024)
Nurture Boss | $4,025,000 | (Dec 4, 2024)
ENAKL | $1,400,000 | (Dec 4, 2024)
MakersHub | $7,000,000 | (Dec 4, 2024)
Freckle (freckle.io) | $1,900,000 | (Dec 3, 2024)
AdvantageClub.ai | $4,000,000 | (Dec 3, 2024)